Inactive Instrument

ME RESO

Equities

MEC

CA5527491032

ME Resource Corp. Nominates Gregory Patience to Join its Board of Directors

February 20, 2013 at 02:07 pm EST

ME Resource Corp. announced that Dr. Gregory Patience has accepted the nomination to join its board of directors. Dr. Patience has extensive experience acting as a consultant to industry, specializing in new technology development, commercialization, process economics and catalysis development.

He is currently an executive at The Canadian Society of Catalyst and was Industrial Chair for the World Congress of Chemical Engineering in 2009.

Latest news about ME RESO

ME Resource Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
Albert Labs Inc. completed the acquisition of ME Resource Corp. in a reverse merger transaction.	22-03-09	CI
ME Resource Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-19	CI
Me Resource Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-19	CI
ME Resource Corp. Reports Earnings Results for the First quarter Ended March 31, 2021	21-05-31	CI
Me Resource Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-29	CI
Albert Labs Inc. entered into a letter of intent to acquire ME Resource Corp. in a reverse merger transaction.	21-01-04	CI
Me Resource Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-27	CI
Me Resource Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-27	CI
Me Resource Corp. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-07-13	CI
ME Resource Corp. Auditor Raises 'Going Concern' Doubt	20-06-15	CI
Me Resource Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	20-06-15	CI
Me Resource Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-22	CI
Me Resource Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-21	CI
Me Resource Corp. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-29	CI
Me Resource Corp. Reports Earnings Results for the Full Year Ended December 31, 2018	19-05-02	CI
ME Resource Corp. Auditor Raises 'Going Concern' Doubt	19-05-01	CI
1113131 B.C. LTD. cancelled the acquisition of ME Resource Corp. in a reverse merger transaction.	19-02-27	CI
ME Resource Corp. Auditor Raises 'Going Concern' Doubt	18-04-29	CI
1113131 B.C. LTD. entered into a letter of intent to acquire ME Resource Corp. (OTCPK:MEEX.F) in a reverse merger transaction.	18-01-01	CI
ME Resource Corp. Auditor Raises 'Going Concern' Doubt	17-04-30	CI
ME Resource Corp. Collaborates with Ineratec GmbH Developing Commercial Mobile Refinery Unit	16-10-31	CI
ME Resource Corp. announced that it has received CAD 0.04 million in funding	16-10-19	CI
ME Resource Corp. announced that it expects to receive CAD 0.2 million in funding	16-08-10	CI
ME Resource Corp. Auditor Raises 'Going Concern' Doubt	16-04-28	CI

Chart ME RESO

Duration

Period

More charts

Company Profile

Albert Labs International Corp., formerly ME Resource Corp., is a Canada-based psychedelics company. The Company is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The Company focuses on treating patients with urgent and unmet mental health needs, starting with cancer-related anxiety. It is also focused on improving patient access to psychedelic-assisted therapies. The Company has an asset-light business model, leveraging existing clinical infrastructure and patient pools by collaborating with research institutions, medical centers and reimbursement networks. The Company uses an accelerated pathway, Real-World Evidence (RWE) studies, to provide access to patients in need. It also provides in-house lab results in formulation.

Sector

More about the company